Erratum to Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients

Affiliations

• ¹ Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
• ² Department of Pulmonary Medicine, Second Affiliated Hospital of Fujian Medical University, Quanzhou 362100, China.
• ³ Department of Respiratory Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.
• ⁴ Department of Respiratory Medicine, Daping Hospital, Chongqing 400042, China.
• ⁵ Department of Respiratory Medicine, Xinqiao Hospital, Army Medical University, Chongqing 400037, China.
• ⁶ Department of Medical Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China.
• ⁷ Department of Thoracic Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China.
• ⁸ Department of Medical Oncology, Hunan Cancer Hospital, Changsha 410006, China.
• ⁹ Department of Pathology, Xiangya Hospital, Central South University, Changsha 410008, China.
• ¹⁰ Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha 410008, China.
• ¹¹ Burning Rock Biotech, Guangzhou 510300, China.
• ¹² Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.